Eduardo Benchimol Saad
Sixth year medical student - The Federal University of Rio de Janeiro
The PAMI Stent Pilot Study was presented, which showed the safety and efficacy of Stent implantation in the AMI setting. In 312 patiens, TIMI flow III was achieved in 97 % of patients ( x 93 % in PTCA ). There was no episodes of subacute thrombosis after a regimen of 48 h of Heparin followed by treatment with aspirin and ticlopidine.
The BERT 1 study showed that b endovascular irradiation can reduce the rate of reestenosis in a small group of patients studies, while the FLARE Trial showed no difference in the reestenosis ( 28 % x 30 % ) rate in patients receeving Fluvastatin 80 mg/day after successful PTCA when compared with placebo.
The UAB Trial implanted Carotid Stents in 254 patients, 80 % of which with concomitant coronary artery disease ( 86 % of whom would be excluded by the NASCET carotid endarterectomy study ). Technical success was achieved in 98 % of cases, with a combined end point of Major Stroke and Death of 2.4 % . Minor Stroke occured in 6 %, half of which was unnoticed by patients. There was 1 acute Stent thrombosis and no subacute thrombosis. The reestenosis rate was an impressevely 6 %, showing that Carotid Stents can be a safe and effective alternative to Carotid Endarterectomy in patients with Carotid lesions of more than 70 %.
2 ) Unstable Angina / Non Q wave AMI
5 ) Atrial Fibrilation and Atrial Flutter
Back to ACC 97
Back to Medstudents' Homepage